Zeke Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.03M | Sell |
|
|||||
|
2022
Q3 | $2.86M | Hold |
|
|||||
|
2022
Q2 | $2.08M | Sell |
|
|||||
|
2022
Q1 | $2.55M | Buy |
|
|||||
|
2021
Q4 | $2.43M | Buy |
|
|||||
|
2021
Q3 | $2.47M | Hold |
|
|||||
|
2021
Q2 | $2.22M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $611K | Sell |
|
|||||
|
2019
Q3 | $528K | Sell |
|
|||||
|
2019
Q2 | $581K | Buy |
|
|||||
|
2019
Q1 | $680K | Sell |
|
|||||
|
2018
Q4 | $708K | Buy |
|
|||||
|
2018
Q3 | $644K | Buy |
|